Cytomed Therapeutics six-month loss narrows to S$1.79m
Cytomed Therapeutics posted a loss of S$1.79 million for the six months ended June 30, 2026, narrowing from S$2.25 million in the prior year. Revenue rose to S$157,289 from S$155,887.
Cytomed Therapeutics posted a loss of S$1.79 million for the six months ended June 30, 2026, narrowing from S$2.25 million in the prior year. Revenue rose to S$157,289 from S$155,887.